Cargando…

The effect of a ketogenic diet on weight loss in CKD: a randomized controlled trial in obese stage G1–3a CKD patients

This study describes a multicentre randomized controlled trial comparing the effects of a ketogenic diet with a low-energy standard diet containing 0.8 g/kg/day on weight loss and metabolic alterations in adult patients with mild-to-moderate non-diabetic chronic kidney disease (CKD) and mild-to-seve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zoccali, Carmine, Bellizzi, Vincenzo, Minutolo, Roberto, Mallamaci, Francesca, Conte, Giuseppe, De Nicola, Luca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	CKJ Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689131/ https://www.ncbi.nlm.nih.gov/pubmed/38045995 http://dx.doi.org/10.1093/ckj/sfad176

Ejemplares similares

Thiazide diuretics are back in CKD: the case of chlorthalidone
por: Minutolo, Roberto, et al.
Publicado: (2022)

Epidemiology of CKD Regression in Patients under Nephrology Care
por: Borrelli, Silvio, et al.
Publicado: (2015)

Uric acid lowering for slowing CKD progression after the CKD-FIX trial: a solved question or still a dilemma?
por: Leoncini, Giovanna, et al.
Publicado: (2022)

Leukocyte–endothelial interaction in CKD
por: Sarakpi, Tamim, et al.
Publicado: (2023)

Plant-based diets for CKD patients: fascinating, trendy, but feasible? A green nephrology perspective
por: Torreggiani, Massimo, et al.
Publicado: (2022)

Pharmacokinetic relevance of glomerular hyperfiltration for drug dosing
por: Zoccali, Carmine, et al.
Publicado: (2023)

Management of fracture risk in CKD—traditional and novel approaches
por: Haarhaus, Mathias, et al.
Publicado: (2022)

What is central to renal nutrition: protein or sodium intake?
por: Wang, Angela Yee-Moon, et al.
Publicado: (2023)

The emerging role of iron in heart failure and vascular calcification in CKD
por: Ciceri, Paola, et al.
Publicado: (2020)

Can we reverse arterial stiffness by intervening on CKD-MBD biomarkers?
por: Vervloet, Marc G
Publicado: (2023)

Donor obesity and weight gain after transplantation: two still overlooked threats to long-term graft survival
por: Kanbay, Mehmet, et al.
Publicado: (2022)

Unmet needs in clinical trials in CKD: questions we have not answered and answers we have not questioned
por: Levin, Adeera, et al.
Publicado: (2022)

The anaemia treatment journey of CKD patients: from epoetins to hypoxia-inducible factor-prolyl hydroxylase inhibitors
por: Locatelli, Francesco, et al.
Publicado: (2023)

Drugs with a negative impact on cognitive functions (Part 2): drug classes to consider while prescribing in CKD patients
por: Hafez, Gaye, et al.
Publicado: (2023)

The long-term benefits of early intensive therapy in chronic diseases—the legacy effect
por: Zoccali, Carmine, et al.
Publicado: (2023)

Vitamin D and methylarginines in chronic kidney disease (CKD)
por: Torino, Claudia, et al.
Publicado: (2017)

Pro-inflammatory cytokines and bone fractures in CKD patients. An exploratory single centre study
por: Panuccio, Vincenzo, et al.
Publicado: (2012)

Venous bicarbonate and CKD progression: a longitudinal analysis by the group-based trajectory model
por: D'Arrigo, Graziella, et al.
Publicado: (2023)

An introduction to inverse probability of treatment weighting in observational research
por: Chesnaye, Nicholas C, et al.
Publicado: (2021)

Are there sex differences in cardiovascular outcomes in non-dialysis CKD patients?
por: Provenzano, Pasquale Fabio, et al.
Publicado: (2023)

A new series of advanced-level research methods papers
por: Jager, Kitty J, et al.
Publicado: (2020)

Homoarginine and Mortality in Pre-Dialysis Chronic Kidney Disease (CKD) Patients
por: Ravani, Pietro, et al.
Publicado: (2013)

New-onset anemia and associated risk of ESKD and death in non-dialysis CKD patients: a multicohort observational study
por: Minutolo, Roberto, et al.
Publicado: (2022)

Assessment of hypertension in kidney transplantation by ambulatory blood pressure monitoring: a systematic review and meta-analysis
por: Pisano, Anna, et al.
Publicado: (2021)

Assessing physical activity and function in patients with chronic kidney disease: a narrative review
por: Bakker, Esmée A, et al.
Publicado: (2020)

Translational research in nephrology: prognosis
por: Tripepi, Giovanni, et al.
Publicado: (2021)

External validation of prognostic models: what, why, how, when and where?
por: Ramspek, Chava L, et al.
Publicado: (2020)

An introduction to joint models—applications in nephrology
por: Chesnaye, Nicholas C, et al.
Publicado: (2020)

Current Management of Hyperkalemia in Non-Dialysis CKD: Longitudinal Study of Patients Receiving Stable Nephrology Care
por: Borrelli, Silvio, et al.
Publicado: (2021)

Pharmacoepidemiology for nephrologists (part 1): concept, applications and considerations for study design
por: Trevisan, Marco, et al.
Publicado: (2020)

Conducting correlation analysis: important limitations and pitfalls
por: Janse, Roemer J, et al.
Publicado: (2021)

Serum Erythroferrone Levels Associate with Mortality and Cardiovascular Events in Hemodialysis and in CKD Patients: A Two Cohorts Study
por: Spoto, Belinda, et al.
Publicado: (2019)

Pharmacoepidemiology for nephrologists (part 2): potential biases and how to overcome them
por: Fu, Edouard L, et al.
Publicado: (2020)

Citation classics: ranking of the top 100 most cited articles in nephrology
por: Montinaro, Vincenzo, et al.
Publicado: (2018)

Ferric Carboxymatose in Non-Hemodialysis CKD Patients: A Longitudinal Cohort Study
por: Minutolo, Roberto, et al.
Publicado: (2021)

Antiproteinuric effect of add-on paricalcitol in CKD patients under maximal tolerated inhibition of renin-angiotensin system: a prospective observational study
por: De Nicola, Luca, et al.
Publicado: (2012)

Shedding a light on sex disparity in clinical trials in CKD patients
por: Mallamaci, Francesca, et al.
Publicado: (2023)

Nutritional treatment of advanced CKD: twenty consensus statements
por: Cupisti, Adamasco, et al.
Publicado: (2018)

The dysfunctional endothelium in CKD and in cardiovascular disease: mapping the origin(s) of cardiovascular problems in CKD and of kidney disease in cardiovascular conditions for a research agenda
por: Fliser, Danilo, et al.
Publicado: (2011)

Mineralocorticoid receptor antagonist use in chronic kidney disease with type 2 diabetes: a clinical practice document by the European Renal Best Practice (ERBP) board of the European Renal Association (ERA)
por: Sarafidis, Pantelis, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_nq7tb7bbvl76ecodp2orqukgek